The ethics and regulatory landscape of including vulnerable populations in pragmatic clinical trials.
about
Stakeholders' views on the ethical challenges of pragmatic trials investigating pharmaceutical drugs.Exploring the ethical and regulatory issues in pragmatic clinical trials.A pragmatic analysis of vulnerability in clinical research.Is Safety in the Eye of the Beholder? Safeguards in Research With Adults With Intellectual Disability.Is It Worth It? Benefits in Research With Adults With Intellectual Disability.Pragmatic clinical trials embedded in healthcare systems: generalizable lessons from the NIH Collaboratory.Characterizing expanded access and compassionate use programs for experimental drugs.Differentiating Research, Quality Improvement, and Case Studies to Ethically Incorporate Pregnant Women.Methodological and Ethical Issues in Pediatric Medication Safety Research.Teens and Research.Combining value of information analysis and ethical argumentation in decisions on participation of vulnerable patients in clinical research.Mode 2 Knowledge Production in the Context of Medical Research: A Call for Further Clarifications.Applications for Bacteriophage Therapy during Pregnancy and the Perinatal Period.Ethical issues in pragmatic randomized controlled trials: a review of the recent literature identifies gaps in ethical argumentation.Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines.Electronic Informed Consent to Facilitate Recruitment of Pregnant Women Into Research
P2860
Q27332116-DB7FC2FC-679A-49FA-B311-6B2D1394AB31Q36963233-C479A3D4-2AEE-49E0-BBD6-5A958075A99BQ38635385-71DB3A0B-A99E-4123-A9B1-D62444715063Q38866477-B9EBBEBE-F9D1-424D-B12C-A2422EA9CFF7Q39022116-CFA4643B-5652-4CF2-B51C-0B465A5BDEF8Q41711992-217959AA-E239-438B-9A4B-8CA405B33E39Q42184966-CA8D74C8-8FB8-4AB6-9CDD-6B4007FF74CAQ47240207-E8CE6A28-2B60-484E-9DF2-75D3C9A3D7D1Q47304205-D0122159-77E5-4A7C-934A-445CBA6933D5Q47658318-4A7F2713-CA76-4A08-95F2-3A3FD5DE7289Q48103834-40CF53B6-6A9F-48C0-BD21-3E379E9F71D9Q48136751-B30B3162-B1DD-4BFF-AC93-0E1FCC63E7BAQ49631079-7E257B4A-AB17-4444-88C6-6B952E6E1244Q50354508-2CFD8351-988A-47DF-A81F-14FF6E02BEB6Q55052878-AF7B3C56-F5A1-44AC-982C-6B49DFD403FFQ56530375-4C55C122-DEB6-4255-9919-17BE5A6730BF
P2860
The ethics and regulatory landscape of including vulnerable populations in pragmatic clinical trials.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
The ethics and regulatory land ...... in pragmatic clinical trials.
@ast
The ethics and regulatory land ...... in pragmatic clinical trials.
@en
type
label
The ethics and regulatory land ...... in pragmatic clinical trials.
@ast
The ethics and regulatory land ...... in pragmatic clinical trials.
@en
prefLabel
The ethics and regulatory land ...... in pragmatic clinical trials.
@ast
The ethics and regulatory land ...... in pragmatic clinical trials.
@en
P2093
P2860
P356
P1433
P1476
The ethics and regulatory land ...... in pragmatic clinical trials.
@en
P2093
Arthur L Caplan
Darcy M Louzao
Gina Uhlenbrauck
James H Fischer
Lynda Brodsky
Mary Jane Welch
Rachel Lally
Stephanie Pittman
P2860
P304
P356
10.1177/1740774515597701
P577
2015-09-15T00:00:00Z